Advertisement

Insecta Class: Flies and Mosquitoes

  • Kavya Desai
  • Campbell StewartEmail author
Chapter
  • 38 Downloads

Abstract

Flies and mosquitoes are essential players in the ecosystem; however, they have a significant impact on human health. These insects can be nuisances through their sheer presence and their bite reactions, but most importantly they are vectors for some of the most devastating diseases on the planet.

Keywords

Diptera Aedes mosquitoes Yellow fever Dengue fever Zika Anopheles mosquitoes Malaria West Nile virus Leishmaniasis 

References

  1. 1.
  2. 2.
    Centers for Disease Control. Dengue and the Aedes aegypti mosquito. 2012, January 30. Retrieved February 1, 2019, from https://www.cdc.gov/dengue/resources/30jan2012/aegyptifactsheet.pdf.
  3. 3.
    Centers for Disease Control. Comparison between main dengue vectors. 2012, January 30. Retrieved February 1, 2019, from https://www.cdc.gov/dengue/resources/30jan2012/comparisondenguevectors.pdf.
  4. 4.
    Centers for Disease Control. Dengue and the Aedes albopictus mosquito. 2012, January 30. Retrieved February 1, 2019, from https://www.cdc.gov/dengue/resources/30jan2012/albopictusfactsheet.pdf.
  5. 5.
    Higuera A, Ramírez JD. Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya arboviruses: an update. Acta Trop. 2019;190:99–111.  https://doi.org/10.1016/J.ACTATROPICA.2018.11.010.CrossRefPubMedGoogle Scholar
  6. 6.
    Domingo C, Escadafal C, Rumer L, Mendez JA, Carcia P, Sall AA, …, Niedrig M. First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS ONE. 2012;7(5):1–11. https://doi-org.ezproxy.libraries.wright.edu/10.1371/journal.pone.0036291.
  7. 7.
    Centers for Disease Control. Transmission of yellow fever virus. 2019, January 15. Retrieved March 3, 2019, from https://www.cdc.gov/yellowfever/transmission/index.html.
  8. 8.
    Lupi O, Tyring SK. Tropical dermatology: viral tropical diseases. J Am Acad Dermatol. 2003;49(6):979–1000.  https://doi.org/10.1016/S0190-9622(03)02727-0.CrossRefPubMedGoogle Scholar
  9. 9.
    Centers for Disease Control. Clinical and laboratory evaluation. 2015, August 21. Retrieved March 3, 2019, from https://www.cdc.gov/yellowfever/healthcareproviders/healthcareproviders-clinlabeval.html.
  10. 10.
    Sako EY, Rubin A, Young LC. Localized bullous fixed drug eruption following yellow fever vaccine. J Am Acad Dermatol. 2014;70:e113–4.CrossRefGoogle Scholar
  11. 11.
    Karouni M, Kurban M, Abbas O. Lichen striatus following yellow fever vaccination in an adult woman. Clin Exp Dermatol. 2017;42(7):823–4.  https://doi.org/10.1111/ced.13167.CrossRefPubMedGoogle Scholar
  12. 12.
    Julander JG. Experimental therapies for yellow fever. Antiviral Res. 2012;97(2):169–79.CrossRefGoogle Scholar
  13. 13.
    Centers for Disease Control. Yellow fever vaccine recommendations. 2019, January 16. Retrieved March 3, 2019, from https://www.cdc.gov/yellowfever/vaccine/vaccine-recommendations.html.
  14. 14.
    World Health Organization. Dengue and severe dengue. 2018, September 13. Retrieved March 5, 2019, from https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.
  15. 15.
    Thomas EA, John M, Kanish B. Mucocutaneous manifestations of dengue fever. Indian J Dermatol. 2010;55(1):79–85.CrossRefGoogle Scholar
  16. 16.
    Rajapakse S, Rodrigo C, Rajapakse AC. Treatment of dengue fever. Infect Drug Resist. 2012;5:103–12.CrossRefGoogle Scholar
  17. 17.
    World Health Organization. Chikungunya. 2012, April 26. Retrieved from https://www.who.int/ith/diseases/chikungunya/en/.
  18. 18.
    Centers for Disease Control. Chikungunya virus in the United States | Chikungunya virus | CDC. n.d. Retrieved February 1, 2019, from https://www.cdc.gov/chikungunya/geo/united-states.html.
  19. 19.
    Inamadar AC, Palit A, Sampagavi VV, Raghunath S, Deshmukh NS. Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India. Int J Dermatol. 2008;47(2):154–9.  https://doi.org/10.1111/j.1365-4632.2008.03478.x.CrossRefPubMedGoogle Scholar
  20. 20.
    LaRocque RL, Ryan ET. Personal actions to minimize mosquito-borne illnesses, including Zika virus. Ann Intern Med;165:589–590.  https://doi.org/10.7326/m16-1397.
  21. 21.
    Farahnik B, Beroukhim K, Blattner CM, Young J. Cutaneous manifestations of the Zika virus. J Am Acad Dermatol. 2016;74(6):1286–7.  https://doi.org/10.1016/J.JAAD.2016.02.1232.CrossRefPubMedGoogle Scholar
  22. 22.
    Centers for Disease Control. Transmission methods. 2019, January 9. Retrieved February 5, 2019, from https://www.cdc.gov/zika/prevention/transmission-methods.html.
  23. 23.
    MacDonald PDM, Holden EW. Zika and public health: understanding the epidemiology and information environment. Pediatrics. 2018;141(2):S137–45.  https://doi.org/10.1542/peds.2017-2038B.CrossRefPubMedGoogle Scholar
  24. 24.
    Satterfield-Nash A, Kotzky K, Allen J, et al. Health and development at age 19–24 months of 19 children who were born with microcephaly and laboratory evidence of congenital Zika virus infection during the 2015 Zika virus outbreak. MMWR Morb Mortal Wkly Rep. 2017;66:1347–52. doi:http://dx.doi.org/10.15585/mmwr.mm6649a2.
  25. 25.
    Wolford RW, Schaefer TJ. Zika virus. [Updated 2018 Nov 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 January. https://www.ncbi.nlm.nih.gov/books/NBK430981/.
  26. 26.
    Rawal G, Yadav S, Kumar R. Zika virus: an overview. J Fam Med Prim Care. 2016;5(3):523–7.  https://doi.org/10.4103/2249-4863.197256.CrossRefGoogle Scholar
  27. 27.
    Malaria. 2018, November 14. Retrieved February 1, 2019, from https://www.cdc.gov/malaria/about/biology/index.html.
  28. 28.
    Centers for Disease Control. Malaria’s impact worldwide. n.d. Retrieved February 1, 2019, from https://www.cdc.gov/malaria/malaria_worldwide/impact.html.
  29. 29.
    World Health Organization. World Malaria Report 2018. Geneva; 2018. License: CC BY-NC-SA 3.0 IGO.Google Scholar
  30. 30.
    World Health Organization. Guidelines for the treatment of malaria, 3rd ed. Geneva; 2015.Google Scholar
  31. 31.
    Vaishnani JB. Cutaneous findings in five cases of malaria. Indian J Dermatol Venereol Leprol. 2011;77(1):110. Retrieved February 5, 2019, from http://www.ijdvl.com/article.asp?issn=0378-6323;year=2011;volume=77;issue=1;spage=110;epage=110;aulast=Vaishnani.
  32. 32.
    Sharma A, Sharma V. Purpura fulminans: an unusual complication of malaria. Braz J Infect Dis. 2013;17(6):712–3.  https://doi.org/10.1016/j.bjid.2013.04.013.CrossRefPubMedGoogle Scholar
  33. 33.
    Tangpukdee N, Duangdee C, Wilairatana P, Krudsood S. Malaria diagnosis: a brief review. Korean J Parasitol. 2009;47(2):93–102.CrossRefGoogle Scholar
  34. 34.
    Centers for Disease Control. Guidelines for treatment of malaria in the United States. 2013, July 1. Retrieved February 1, 2019, from https://www.cdc.gov/malaria/resources/pdf/treatmenttable.pdf.
  35. 35.
    Lalloo DG, Hill DR. Preventing malaria in travellers. BMJ (Clin Res Ed). 2008;336(7657):1362–6Google Scholar
  36. 36.
    Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, Battle K, Moyes CL, Henry A, Eckhoff PA, Wenger EA, Briët O, Penny MA, Smith TA, Bennett A, Yukich J, Eisele TP, Griffin JT, Fergus CA, Lynch M, Lindgren F, Cohen JM, Murray C, Smith DL, Hay SI, Cibulskis RE, … Gething PW. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526(7572):207–11.Google Scholar
  37. 37.
    World Health Organization. Mosquitoes and other biting diptera. Retrieved April 7, 2019, from https://www.who.int/water_sanitation_health/resources/vector007to28.pdf.
  38. 38.
    Shenoy RK. Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol. 2008;46(3):119–25.  https://doi.org/10.3347/kjp.2008.46.3.119.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    World Health Organization. Lymphatic filariasis epidemiology. Retrieved April 5, 2019, from https://www.who.int/lymphatic_filariasis/epidemiology/en/.
  40. 40.
    Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, …, Hoerauf A. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog. 2006;2(9):e92.  https://doi.org/10.1371/journal.ppat.0020092.
  41. 41.
    Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. West Nile virus: biology, transmission, and human infection. Clin Microbiol Rev. 2012;25(4):635–48.  https://doi.org/10.1128/cmr.00045-12.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Maroli M, Feliciangeli D, Bichaud L, Charrel R, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Medical Vet Entomol J. 2012;27:123–47.CrossRefGoogle Scholar
  43. 43.
    Masmoudi A, Hariz W, Marrekchi S, Amouri M, Turki H. Old world cutaneous leishmaniasis: diagnosis and treatment. J Dermatol Case Rep. 2013;7(2):31–41.  https://doi.org/10.3315/jdcr.2013.1135.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581–96.CrossRefGoogle Scholar
  45. 45.
    Temocin F, Sari T, Tulek N. Sandfly fever with skin lesions: a case series from Turkey. J Arthropod-Borne Dis. 2016;10(4):608–12.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Kocak Tufan Z, Tasyaran MA, Guven T. Sandfly fever: a mini review. Virol Mycol. 2013;2:109.CrossRefGoogle Scholar
  47. 47.
    Özkale Y, Özkale M, Kiper P, Çetinkaya B, Erol İ. Sadfly fever: two case reports. Turk Pediatr Ars. 2016;51(2):110–3.  https://doi.org/10.5152/TurkPediatriArs.2015.1734.CrossRefGoogle Scholar
  48. 48.
    Sundar S. Visceral leishmaniasis. Trop Parasitol. 2015;5(2), 83–85.  https://doi.org/10.4103/2229-5070.162487.
  49. 49.
    Moore EM, Lockwood DN. Treatment of visceral leishmaniasis. J Glob Infect Dis. 2010;2(2):151–8.  https://doi.org/10.4103/0974-777X.62883.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Hill CA, Platt J, MacDonald JF. Black flies: biology and public health risk. 2010, May. Retrieved April 30, 2019, from https://extension.entm.purdue.edu/publications/E-251.pdf.
  51. 51.
    Centers for Disease Control. Onchocerciasis disease. 2013, May 21. Retrieved April 29, 2019, from https://www.cdc.gov/parasites/onchocerciasis/disease.html.
  52. 52.
    Centers for Disease Control. Onchocerciasis epidemiology and risk factors. 2013, May 21. Retrieved April 29, 2019, from https://www.cdc.gov/parasites/onchocerciasis/epi.html.
  53. 53.
    Stingl P. Onchocerciasis: developments in diagnosis, treatment and control. Int J Dermatol. 2009;48(4):393–6.  https://doi.org/10.1111/J.1365-4632.2009.03843.X.CrossRefPubMedGoogle Scholar
  54. 54.
    Desquesnes M, Wongthangsiri D, Jittapalapong S, Chareonviriyaphap T. Guidelines for user-friendly iconographic description of hematophagous flies’ external morphology; application to the identification of Tabanus rubidus (Wiedemann, 1821) (Diptera: Tabanidae). J Asia-Pac Entomol. 2018;21(3):807–22.  https://doi.org/10.1016/J.ASPEN.2018.06.005.CrossRefGoogle Scholar
  55. 55.
    Whittaker C, Walker M, Pion SD, Chesnais CB, Boussinesq M, Basáñez M. The population biology and transmission dynamics of loa loa. Trends Parasitol. 2018;34(4):335–50.  https://doi.org/10.1016/J.PT.2017.12.003.CrossRefPubMedGoogle Scholar
  56. 56.
    Whittaker C, Walker M, Pion SD, Chesnais CB, Boussinesq M, Basáñez M. The population biology and transmission dynamics of loa loa. Trends in Parasitology. 2018;34(4):335–50.  https://doi.org/10.1016/j.pt.2017.12.003.
  57. 57.
    Sadia A, Fisher M, Juckett G. The African eye worm: a case report and review. J Travel Med. 2008;15(1):50–2.  https://doi.org/10.1111/j.1708-8305.2007.00166.x.
  58. 58.
    Centers for Disease Control. Loiasis prevention and control. 2015, Jan 20. Retrieved April 30, 2019, from https://www.cdc.gov/parasites/loiasis/prevent.html.
  59. 59.
    World Health Organization. Human African Trypansomiasis the vector (tsetse fly). Retrieved April 30, 2019, from https://www.who.int/trypanosomiasis_african/disease/vector/en/.
  60. 60.
    World Health Organization. Human African Trypansomiasis the transmission cycle. Retrieved April 30, 2019, from https://www.who.int/trypanosomiasis_african/disease/transmission_cycle/en/.
  61. 61.
    World Health Organization. Human African Trypansomiasis epidemiological situation. Retrieved April 30, 2019, from https://www.who.int/trypanosomiasis_african/country/en/.
  62. 62.
    Natuva DP, Brahmani S, Subbarao K, Padma B, Anil B, Koppulo S, Rao CB. Molecular mechanisms and therapeutic approaches to the treatment of African Trypanosomiasis. Drug Inven Today. 2012;4(5):381–388. Retrieved from https://search-ebscohost-com.ezproxy.libraries.wright.edu/login.aspx?direct=true&db=a9h&AN=100835130&site=eds-live.
  63. 63.
    Centers for Disease Control. Sleeping sickness diagnosis. 2012, Aug 29. Retrieved April 30, 2019, from https://www.cdc.gov/parasites/sleepingsickness/diagnosis.html.
  64. 64.
    World Health Organization. Human African Trypansomiasis symptoms, diagnosis and treatment. Retrieved April 30, 2019, from https://www.who.int/trypanosomiasis_african/disease/diagnosis/en/.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Internal Medicine and DermatologyThe University if MinnesotaMinneapolisUSA
  2. 2.Uconn HealthFarmingtonUSA

Personalised recommendations